← All trials
NCT04767191
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- May 31, 2022
- First posted
- Feb 23, 2021
- Last posted
- Nov 17, 2021
- Enrollment
- 400
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- JhpiegoLead sponsor
- United States Agency for International DevelopmentCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- Kenya Ministry of HealthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.